148 related articles for article (PubMed ID: 19656169)
41. Effects of phospholipase A2, free fatty acids and 2-lysolecithin on the crystallization of cholesterol in gallbladder bile.
Schöne A; Jüngst D; Meyer G; Hernandez-Richter T; Fischer S
Eur J Clin Invest; 2000 Aug; 30(8):715-21. PubMed ID: 10964164
[TBL] [Abstract][Full Text] [Related]
42. Increased biliary group II phospholipase A2 and altered gallbladder bile in patients with multiple cholesterol stones.
Shoda J; Ueda T; Ikegami T; Matsuzaki Y; Satoh S; Kano M; Matsuura K; Tanaka N
Gastroenterology; 1997 Jun; 112(6):2036-47. PubMed ID: 9178697
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile.
Fischer S; Dolu MH; Zündt B; Meyer G; Geisler S; Jüngst D
Eur J Clin Invest; 2001 Sep; 31(9):789-95. PubMed ID: 11589721
[TBL] [Abstract][Full Text] [Related]
44. Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis.
Lammert F; Wang DQ; Hillebrandt S; Geier A; Fickert P; Trauner M; Matern S; Paigen B; Carey MC
Hepatology; 2004 Jan; 39(1):117-28. PubMed ID: 14752830
[TBL] [Abstract][Full Text] [Related]
45. Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients.
van Erpecum KJ; Portincasa P; Dohlu MH; van Berge-Henegouwen GP; Jüngst D
J Hepatol; 2003 Jul; 39(1):7-11. PubMed ID: 12821037
[TBL] [Abstract][Full Text] [Related]
46. Assessment of 'nucleation time' as a predictor of cholelithiasis.
Abeysuriya V; Deen KI; Kumarage SK; Navarathne NM
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1020-3. PubMed ID: 18787471
[TBL] [Abstract][Full Text] [Related]
47. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients.
van Erpecum KJ; van Berge Henegouwen GP; Stoelwinder B; Schmidt YM; Willekens FL
Hepatology; 1990 Jan; 11(1):1-6. PubMed ID: 2295460
[TBL] [Abstract][Full Text] [Related]
48. Solitary versus multiple cholesterol gallbladder stones. Mechanisms of formation and growth.
Wolpers C; Hofmann AF
Clin Investig; 1993 Jun; 71(6):423-34. PubMed ID: 8353400
[TBL] [Abstract][Full Text] [Related]
49. Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones.
Jüngst D; Lang T; von Ritter C; Pratschke E; Paumgartner G
Hepatology; 1992 May; 15(5):804-8. PubMed ID: 1568721
[TBL] [Abstract][Full Text] [Related]
50. Sensitivity and specificity of microscopic examination of gallbladder bile for gallstone recognition and identification.
Ramond MJ; Dumont M; Belghiti J; Erlinger S
Gastroenterology; 1988 Nov; 95(5):1339-43. PubMed ID: 3049219
[TBL] [Abstract][Full Text] [Related]
51. Biliary proteins and the nucleation defect in cholesterol cholelithiasis.
Gallinger S; Harvey PR; Petrunka CN; Ilson RG; Strasberg SM
Gastroenterology; 1987 Apr; 92(4):867-75. PubMed ID: 3556994
[TBL] [Abstract][Full Text] [Related]
52. Measurement of cholesterol gallstone growth in vitro.
van Den Berg AA; van Buul JD; Ostrow JD; Groen AK
J Lipid Res; 2000 Feb; 41(2):189-94. PubMed ID: 10681401
[TBL] [Abstract][Full Text] [Related]
53. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
[TBL] [Abstract][Full Text] [Related]
54. The physical presence of gallstone modulates
Portincasa P; van Erpecum KJ; Di Ciaula A; Wang DQ
Gastroenterol Rep (Oxf); 2019 Feb; 7(1):32-41. PubMed ID: 30792864
[TBL] [Abstract][Full Text] [Related]
55. Total biliary protein, mucus glycoproteins, cyclic-AMP, and apolipoproteins in the gallbladder bile of patients with cholesterol stones and stone-free controls.
Swobodnik W; Wenk H; Janowitz P; Hagert N; Kratzer W; Berghold J; Zhang Y; Bittner R; Schusdziarra V; Ott R
Scand J Gastroenterol; 1991 Jul; 26(7):771-8. PubMed ID: 1654593
[TBL] [Abstract][Full Text] [Related]
56. Biliary lipid excretion in patients with pigment gallstones. A comparison with cholesterol gallstone patients.
Wagner CI; Trotman BW; Soloway RD
Am J Dig Dis; 1978 Jan; 23(1):85-8. PubMed ID: 619630
[TBL] [Abstract][Full Text] [Related]
57. Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis.
Venneman NG; Renooij W; Rehfeld JF; VanBerge-Henegouwen GP; Go PM; Broeders IA; van Erpecum KJ
Hepatology; 2005 Apr; 41(4):738-46. PubMed ID: 15793851
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic value of fine-needle puncture of the gallbladder: side effects, safety, and prognostic value.
Tudyka J; Kratzer W; Kuhn K; Janowitz P; Wechsler JG; Adler G
Hepatology; 1995 May; 21(5):1303-7. PubMed ID: 7737635
[TBL] [Abstract][Full Text] [Related]
59. Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones.
Kano M; Shoda J; Irimura T; Ueda T; Iwasaki R; Urasaki T; Kawauchi Y; Asano T; Matsuzaki Y; Tanaka N
Hepatology; 1998 Aug; 28(2):302-13. PubMed ID: 9695991
[TBL] [Abstract][Full Text] [Related]
60. Administration of a terpene mixture inhibits cholesterol nucleation in bile from patients with cholesterol gallstones.
von Bergmann K; Beck A; Engel C; Leiss O
Klin Wochenschr; 1987 May; 65(10):458-62. PubMed ID: 3599793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
